Nference
Date of Posted : Mar 14, 2025
At nFerence Labs, the "Google of Biomedicine" (See nference.ai/media ), where we are building the world's first large-scale computational platform for reverse engineering biology. Just as 20th-century science comprised of the deconstruction of physics unlocking all the engineering and tech applications we are so familiar with, this century is witnessing the deconstruction or reverse engineering of biological systems to unlock all kinds of medical and wellness applications. nFerence is one of the few companies with the data, funding, people, and tech to make significant initial forays into this 21st-century endeavor. Our platform is premised on using AI and high-performance computing to connect clinical observations (phenotypes) to DNA-level phenomena (genotypes); in the process helps unravel biology, as well as help pharma companies, perform faster and more efficient drug discovery, and help early diagnosis of several key diseases. We collaborate heavily with premier medical research institutions to get medical insights from patient information including multiple modalities: text, lab data, images, ECGs, etc. See also anumana.ai, our affiliated company developing cardiology AI; where we are conducting clinical studies for cardiovascular algorithms. Our team is a blend of computer scientists and domain experts (biology and medical MDs, and PhDs from premier universities), and we provide an exciting open fast-paced dynamic workplace designed to foster innovative solutions.